Cyanosis primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measurement for primary prevention include prenatal echocardiography and genetic testing for detecting cyanotic congenital heart disease and prenatal corticosteroid therapy for prevention of neonatal respiratory distress syndrome and development of lung maturation.
Primary prevention
- Effective measurement for primary prevention include prenatal echocardiography and genetic testing for detecting cyanotic congenital heart disease and prenatal corticosteroid therapy for prevention of neonatal respiratory distress syndrome and development of lung maturation.[1]
References
- ↑ Liu, Xiwang; Xu, Weize; Yu, Jiangen; Shu, Qiang (2019). “Screening for congenital heart defects: diversified strategies in current China”. World Journal of Pediatric Surgery. 2 (1): e000051. doi:10.1136/wjps-2019-000051. ISSN 2516-5410.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH